Generics News

Generics News

Lannett Launches Oxycodone HCl Oral Solution

Lannett announced it has begun shipping Oxycodone HCl Oral Solution, which was approved earlier this month.

Lannett Approved for Oxycodone HCl Oral Solution

Lannett announced it has received approval from the Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Oxycodone HCl Oral Solution, the equivalent of Lehigh Valley Technologies' listed reference.

Par Resumes Generic Precedex Shipment

Par announced that it has resumed shipping Dexmedetomidine HCl Injection, the generic version of Hospira's Precedex.

Endo Launches Generic Fortesta Gel

Endo announced the introduction of Testosterone Gel 2%, the generic version of its Fortesta Gel.

Mylan Launches Generic Boniva Injection

Mylan announced the launch of Ibandronate Sodium Injection, the generic version of Roche's Boniva Injection.

Teva Launches Generic Baraclude Tablets

Teva announced the launch of Entecavir Tablets, the generic version of Bristol-Myers Squibb's Baraclude.

InnoPharma Approved for Generic Dacogen

InnoPharma has announced that it has received approval from the Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Decitabine for Injection, a generic version of Eisai's Dacogen.

TWi Pharma Approved for Generic Megace ES

TWi Pharmaceuticals announced that it has received final approval for Megestrol Acetate Suspension, the generic version of Par Pharmaceutical's Megace ES.

Fera to Launch Generic Moxatag

Fera Pharmaceuticals announced it will launch Amoxicillin Extended-Release Tablets, the generic version of Pragma Pharmaceuticals' Moxatag.

Mylan Launches Generic Klor-Con Tablets

Mylan announced its launch of Potassium Chloride Extended-Release Tablets, the generic version of Upsher-Smith's Klor-Con.